| Predominant morphology | ||
| Ulceration | 04 | 14.81 |
| Vegetating | 02 | 7.41 |
| Ulceration and vegetating | 06 | 22.22 |
| Stenosing | 01 | 3.7 |
| Non evaluated | 14 | 51.85 |
| Size of the lesion (cm) | ||
| ≤ 0,5 | 01 | 3.7 |
| 0.6–2.0 | 08 | 29.63 |
| 2.1–5.0 | 15 | 55.56 |
| ≥ 5.1 | 03 | 11.11 |
| UJCC/TNM Staging | ||
| I | 02 | 7.41 |
| II | 02 | 7.41 |
| III | 09 | 33.33 |
| IV | 0 | 0 |
| Non evaluated | 14 | 51.85 |
| Tumor Grade | ||
| Well Differentiated | 06 | 22.22 |
| Moderately Differentiated | 19 | 70.38 |
| Poorly Differentiated | 01 | 3.7 |
| Undifferentiated | 01 | 3.7 |
| Invasion | ||
| Present | 09 | 33.33 |
| Absent | 12 | 44.45 |
| Not evaluated | 06 | 22.22 |
| Infiltration | ||
| Anal canal wall | 01 | 3.7 |
| Perianal region | 01 | 3.7 |
| Perirectal fat | 01 | 3.7 |
| Vagina and uterine cervix | 01 | 3.7 |
| Stroma | 01 | 3.7 |
| Muscle layer | 01 | 3.7 |
| Perineural | 01 | 3.7 |
| Vulvar | 01 | 3.7 |
| Not evaluated | 01 | 3.7 |
| No infiltration | 18 | 66.7 |
| Lymph node involvement | ||
| Yes | 07 | 25.93 |
| No | 15 | 55.55 |
| Not evaluated | 05 | 18.52 |
| Metastasis | ||
| Yes | 03 | 11.11 |
| No | 19 | 70.37 |
| Not evaluated | 05 | 18.52 |
| Inflammatory process | ||
| Yes | 05 | 18.52 |
| No | 12 | 44.44 |
| Not evaluated | 10 | 37.04 |
| Necrosis Presence | ||
| Yes | 02 | 7.41 |
| No | 12 | 44.44 |
| Not evaluated | 13 | 48.15 |